ICH-Q10: A Recipe for the Product Life Cycle - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ICH-Q10: A Recipe for the Product Life Cycle
The draft guidance ICH Q10 for pharmaceutical quality systems is part of the ongoing move to a science- and risk-based approach in manufacturing.


Pharmaceutical Technology


References

1. ICH, ICH Q8 Pharmaceutical Development (ICH, Geneva, Nov. 10, 2005), http://www.ich.org/LOB/media/MEDIA1707.pdf, accessed Aug. 15, 2007.

2. ICH, ICH Q9 Quality Risk Management (ICH, Geneva, Nov. 9, 2005), http://www.ich.org/LOB/media/MEDIA1957.pdf, accessed Aug. 15, 2007.

3. ICH, ICH Q10 Draft Consensus Guideline Pharmaceutical Quality System (ICH, Geneva, May 9, 2007), http://www.ich.org/LOB/media/MEDIA3917.pdf, accessed Aug. 15, 2007.

4. J.C. Famulare, "Pharmaceutical Quality Systems, PQS, Enhanced by QbD for the Product Life Cycle," presented at the ISPE PQLI Workshop, Crystal City, VA, June 2007.

5. FDA, Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations (FDA, Rockville, MD, September 2006), http://www.fda.gov/cder/guidance/7260fnl.htm, accessed Aug. 1, 2007.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
Source: Pharmaceutical Technology,
Click here